Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Valo Health
Biotech
Merck KGaA becomes latest partner for Flagship’s Valo Health
Merck and Valo will use the latter’s discovery platform to quickly craft preclinical candidates for newly identified Parkinson's disease targets.
Darren Incorvaia
Nov 20, 2025 6:30am
Pfizer, Flagship turn to autoimmune for latest angle of collab
Apr 1, 2025 9:38am
Charles River and Valo pact nets preclinical lupus asset
Mar 26, 2025 6:30am
Novo bets $190M near-term on AI pact in obesity, diabetes
Jan 8, 2025 8:00am
Valo abandons ROCK inhibitor after diabetic retinopathy fail
Jan 2, 2025 9:43am
Flagship-backed biotechs name new leaders—Chutes & Ladders
Nov 15, 2024 8:30am